VHCP Management III, LLC
data from 31/12/2019
Capitalization
$ 503.631 M
210.90 %
Performance
$ 85.631 M
61.09 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2019/12/31 | AXSM | Axsome Therapeutics Inc | 31.77% | 160.001 M $ | 1547994 | 2019/03/31 | 133.934 M $ | 410.68 % |
| 2019/12/31 | CNST | Constellation Pharmaceuticals | 23.54% | 118.540 M $ | 2516242 | 2018/09/30 | 2.710 M $ | 628.77 % |
| 2019/12/31 | MIST | Milestone Pharmaceuticals Inc | 6.57% | 33.085 M $ | 2066529 | 2019/06/30 | -5.456 M $ | -14.16 % |
| 2019/12/31 | RLMD | Relmada Therapeutics Inc | 5.95% | 29.950 M $ | 767938 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | ETNB | 89Bio Inc | 5.00% | 25.206 M $ | 958765 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | TXG | 10X Genomics Inc. | 4.54% | 22.875 M $ | 300000 | 2019/09/30 | 7.755 M $ | 51.29 % |
| 2019/12/31 | Forty Seven Inc | 4.04% | 20.330 M $ | 516381 | 2019/12/31 | 0.000 $ | 0.00 % | |
| 2019/12/31 | ITCI | Intra-Cellular Therapies Inc | 3.92% | 19.728 M $ | 575000 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | ISEE | Iveric Bio Inc | 2.90% | 14.584 M $ | 1699797 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | KALV | Kalvista Pharmaceuticals | 2.19% | 11.041 M $ | 619905 | 2018/09/30 | 3.961 M $ | 53.54 % |
| 2019/12/31 | ADVM | Adverum Biotechnologies Inc | 2.16% | 10.901 M $ | 946234 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | Marinus Pharmaceuticals Inc | 2.15% | 10.835 M $ | 5016164 | 2018/09/30 | 1.560 M $ | 40.26 % | |
| 2019/12/31 | MRSN | Mersana Therapeutics Inc | 1.78% | 8.947 M $ | 1561389 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | MYOV | Myovant Sciences Ltd | 1.40% | 7.066 M $ | 455255 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | NXTC | Nextcure Inc | 1.34% | 6.742 M $ | 119693 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | OBSV | Obseva SA | 0.61% | 3.095 M $ | 810264 | 2018/09/30 | -5.231 M $ | -54.14 % |
| 2019/12/31 | PTGX | Protagonist Therapeutics Inc | 0.11% | 571.000 K $ | 80929 | 2018/12/31 | -5.319 M $ | -41.30 % |
| 2019/12/31 | Bellerophon Therapeutics | 0.03% | 134.000 K $ | 383955 | 2018/09/30 | -321.394 K $ | -27.59 % | |
| 2019/12/31 | RDUS | Radius Health Inc | 0.00% | 0.000 $ | 0 | 2019/09/30 | 0.000 $ | 0.00 % |
| 2019/12/31 | RARX | Ra Pharmaceuticals | 0.00% | 0.000 $ | 0 | 2018/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | Proteostasis Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2018/12/31 | 0.000 $ | 0.00 % | |
| 2019/12/31 | LJPC | La Jolla Pharmaceuticals | 0.00% | 0.000 $ | 0 | 2019/03/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | BCRX | BioCryst Pharmaceuticals Inc | 0.00% | 0.000 $ | 0 | 2018/09/30 | 0.000 $ | 0.00 % |
| 2019/12/31 | TCDA | Tricida Inc | 0.00% | 0.000 $ | 0 | 2018/09/30 | 0.000 $ | 0.00 % |
| 2019/12/31 | KNSA | Kiniksa Pharmaceuticals Ltd | 0.00% | 0.000 $ | 0 | 2018/09/30 | 0.000 $ | 0.00 % |
| 2019/12/31 | Prevail Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2019/09/30 | 0.000 $ | 0.00 % |